Cardiology

Canadian Cardiovascular Society issues guidance on management, including use of the new cardiac myosin inhibitor, mavacamten, for symptomatic disease.

Many home blood pressure devices sold in Canada, especially those sold online, haven’t been validated by Hypertension Canada, according to an Edmonton-based study.

Test your knowledge of the assessment and management of TIAs.

Some studies have demonstrated lower mortality with phospho­diesterase-5 inhibitor treatment for erectile dysfunction in men with stable coronary artery disease, compared with no treatment.

Evidence shows it substantially adds to CVD risk, but new policies may help with sodium reduction.

Large study examines rates of eczema (atopic dermatitis) in older adults starting on various classes of antihypertensive drugs.

New study looks at health outcomes of step counts compared to time spent exercising.

A new study examined how often adults are misdiagnosed with CAP and explored some of the more frequent consequences.